Position in ANAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$48,398,445
+$29,306,025 QoQ
Shares Held
717,014
+38.9% QoQ
Ownership
2.46%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#9
of 211 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. ANAB ranks #30 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,002,863 | $375,096,182 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $173,349,326 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
4,000,567 | $125,057,724 | |
| 4 | BHVN |
Biohaven Ltd.
|
7,660,280 | $113,984,966 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,603,162 | $100,742,369 | |
| 6 | CYTK |
Cytokinetics Inc
|
1,100,708 | $93,769,314 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
3,007,798 | $92,730,412 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,500,673 | $88,498,817 |
All Filings in ANAB
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,398,445 | 717,014 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $19,092,420 | 344,256 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $24,289,595 | 501,023 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $15,341,299 | 501,023 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,122,710 | 501,023 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $14,705,078 | 791,023 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,422,390 | 485,073 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $15,409,273 | 459,979 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,324,304 | 252,366 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,459,028 | 508,839 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $25,596,343 | 1,194,974 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $15,101,103 | 840,821 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $21,042,726 | 1,034,549 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $10,000,092 | 459,562 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $20,067,419 | 647,545 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $28,320,288 | 1,110,162 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,688,905 | 920,638 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $20,631,312 | 833,927 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $21,196,870 | 609,981 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $27,498,486 | 1,013,956 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $14,003,575 | 540,052 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $9,241,674 | 428,847 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||